Atlas Trials

High-dose HMG-CoA Inhibitor Simvastatin Relapsed CLL

Clinical trial NCT00828282 · COMPLETED

Trial details

NCT number
NCT00828282
Sponsor
John Haslip
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2009-03-01
Primary completion
2011-01-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.